Increasing the options for effective migraine management

Publisher Website
Google Scholar
Abstract
The chronic nature of migraine imposes a substantial burden on patients, their families, employers, and on society in general. [2] The societal effect of migraine is traditionally measured in economic terms by the direct and indirect costs of the illness. Direct costs include the cost of therapy, whereas indirect costs include the lost productivity that can be attributed to the disease by patients and by the family members who are called on to support them. It is therefore pertinent in considering new options for therapy to consider the ways in which new agents might reduce the direct and indirect costs attributable to the disease, [3] and to look at the epidemiology of the condition.